EquityZen Growth Technology Fund LLC - Series 513
Raised
$179K
Investors
9
Min Invest
$10,004
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 513 is a Delaware-registered pooled investment fund filing under Rule 506(b) and Section 3(c)(1), raising $179K from 9 investors with a $10K minimum investment. Filed May 2020 by EquityZen Advisors and Assure Fund Management II, this is one of 1,891 related entities in the EquityZen pre-IPO platform ecosystem.
This pre-IPO fund follows the standard EquityZen structure: Rule 506(b) private placement combined with 3(c)(1) investment company exemption, targeting accredited retail investors with accessible $10K minimums. The offering size and investor count are consistent with single-company SPVs designed to provide liquidity for shares in private growth-stage technology companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
